New Data Suggest Aranesp(R) Benefits Patients Suffering From Anemia of Cancer, Who Are Not Receiving Chemotherapy Read more about New Data Suggest Aranesp(R) Benefits Patients Suffering From Anemia of Cancer, Who Are Not Receiving Chemotherapy
Analysis of Head-to-Head Studies Shows That Aranesp(R) Dosed Every Two Weeks Offers Similar Results With Less Frequent Administration Compared to Epoetin Alfa Read more about Analysis of Head-to-Head Studies Shows That Aranesp(R) Dosed Every Two Weeks Offers Similar Results With Less Frequent Administration Compared to Epoetin Alfa
Phase 3 Data Show Palifermin Improves Patient Reported Outcomes in Cancer Patients and Helps Reduce Hospitalizations and Healthcare Resources Read more about Phase 3 Data Show Palifermin Improves Patient Reported Outcomes in Cancer Patients and Helps Reduce Hospitalizations and Healthcare Resources
Amgen Names David Beier Senior Vice President, Global Government Affairs Read more about Amgen Names David Beier Senior Vice President, Global Government Affairs
Amgen Forecasts Strong 2004 Financial Performance Read more about Amgen Forecasts Strong 2004 Financial Performance
Amgen Named One of Fortune Magazine's '100 Best Companies to Work For' Read more about Amgen Named One of Fortune Magazine's '100 Best Companies to Work For'
Amgen Opens State-of-the-Art Biotechnology Research Campus Read more about Amgen Opens State-of-the-Art Biotechnology Research Campus
Amgen Announces Webcast of R&D Day With the Investment Community Read more about Amgen Announces Webcast of R&D Day With the Investment Community
Amgen Announces Award for Science Teaching Excellence Read more about Amgen Announces Award for Science Teaching Excellence
Amgen Announces Award for Science Teaching Excellence in Colorado Read more about Amgen Announces Award for Science Teaching Excellence in Colorado
